Clinical Trials Browser

Glioblastoma, Glioma

Glioblastoma

Brain Neoplasms

Recurrent Extensive Stage Small Cell Lung Carcinoma

Diffuse Intrinsic Pontine Glioma

Paraganglioma, Pheochromocytoma

Glioblastoma

Glioblastoma, Recurrence, Disease Progression

Glioblastoma

Glioblastoma

Glioblastoma

Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms Germ Cell and Embryonal Neoplasms by Histologic Type Neoplasms Neoplasms

Sarcoma, Ewing

Glioblastoma

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Neoplasms, Neuroepithelial

Lymphoma, Non-Hodgkin

Small Cell Lung Carcinoma

Leiomyosarcoma

Glioblastoma

Glioblastoma

Glioblastoma

Glioblastoma

Glioblastoma, Glioma

Glioblastoma

Glioblastoma, Glioma, Neoplasms, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Neoplasms, Neuroepithelial

Glioblastoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

Pituitary Neoplasms

Glioblastoma

Glioblastoma

Glioblastoma

Astrocytoma, Oligodendroglioma

Non Small Cell Lung Cancer Metastatic

Glioblastoma

Astrocytoma, Glioblastoma

Colonic Neoplasms, Gallbladder Neoplasms, Glioblastoma, Liver Neoplasms, Multiple Myeloma, Pancreatic Neoplasms, Rectal Neoplasms

Astrocytoma, Glioblastoma, Glioma

Neuroendocrine Tumors

Glioblastoma

Adenoma, Islet Cell

Extrapancreatic Neuroendocrine Tumor

Extensive Stage Small Cell Lung Cancer

Glioblastoma

Clinical Trials

Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas

Sintilimab in Combination With Bevacizumab and Temozolomide in Recurrent Glioblastoma (GBM) Patients

Study of Letrozole in Recurrent Gliomas

HTMC0435 and Temozolomide in Treating Patients With Small Cell Lung Cancer

Nimotuzumab in Combined With Chemoradiotherapy to Treat the Newly Diagnosed Diffuse Intrinsic Pontine Glioma in Children

A Study on the Safety and Effectiveness of Temozolomide for Neoadjuvant Treatment of PPGL

MRSI to Predict Response to RT/TMZ ± Belinostat in GBM

The Efficacy and Safety of Neoadjuvant Toripalimab Combined With Temozolomide in Resectable Stage III Melanoma

RE-GEND

Neoadjuvant Chemoimmunotherapy in Recurrent Glioblastoma

Pilot Study of B7-H3 CAR-T in Treating Patients With Recurrent and Refractory Glioblastoma

LITT Combined With Early Use of Temozolomide for Recurrent Glioblastomas

A Study of HX008 Plus Transcatheter Arterial Chemoembolization (TACE) in the First-Line Treatment of Subjects With Stage IV (M1c) Melanoma That is Metastatic to the Liver

Irinotecan and Temozolomide for Ewing Sarcoma

A Phase III Study of Postoperative Early Temozolomide Treatment Plus STUPP Regimen for Newly Diagnosed GBM Multiforme

HIT-HGG-2013

Ibrutinib With Methotrexate and Temozolomide for Patients With Newly Diagnosed Primary CNS Lymphoma

Study of Olaparib and Temozolomide in Patients With Recurrent Small Cell Lung Cancer Following Failure of Prior Chemotherapy

Temozolomide for Injection Combined With Epirubicin in First-line Treatment of Leiomyosarcoma

TEMOTRAD01

A Study of Toripalimab or Combining With Temozolomide（iv） in the Treatment of Advanced/Metastatic Malignant Melanoma

Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM

Neoadjuvant Temozolomide Combined With Simultaneous IMRT for Treatment of Glioblastoma

Pilot Study of Elemene in Treating Patients With Refractory Glioblastoma

Neoadjuvant PD-1 in Newly Diagnosed Glioblastoma

HUTMZ

A Trail of Fluzoparil in Combination With Temozolomide in Patients With Recurrent Glioblastoma

HSCK-010

Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients.

Camrelizumab Plus Apatinib and Temozolomide as First Line Therapy in Advanced Acral Melanoma

Temozolomide Plus Anti-angiogenesis Drugs and Radiotherapy as a Treatment for Glioblastoma

Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery

The Effect of Chemoradiotherapy in Patients With Refractory Pituitary Adenomas

RACTAC

Addition of Anlotinib Hydrochloride to the Stupp Regimen Versus the Stupp Regimen Alone for Newly Diagnosed Glioblastoma

TMZ Plus Apatinib in Newly Diagnosed High-grade Glioma：RCT

A Study of the Safety and Pharmacokinetics of BRCX014 in Patients With Glioblastoma

A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade Gliomas

Temozolomide Combine With Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Non Small Cell Lung Cancer Brain Metastases

TTFields Together With Temozolomide and Radiotherapy in Patients With Newly Diagnosed GBM

Efficacy of Two Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade Glioma

A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies

A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas

HDI Versus Chemotherapy as Systemic Adjuvant Therapy for Resected Mucosal Melanoma

Study to Compare Capecitabine Combined With Dacarbazine(CAPDTIC) Versus Capecitabine Combined Temozolomide(CAPTEM) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine Tumor

Application of Proteome Profiler Antibody Arrays to Find Angiogenetic Predictors in Glioma Paitents.

A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Pancreatic Neuroendocrine Tumor

A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Extrapancreatic Neuroendocrine Tumor

Extensive Stage Sclc Patients Who Were Benefit From First-line Treatment Accept Temozolomide Maintain Therapeutic

Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma